1. Introduction {#sec1}
===============

The *Theileria* are apicomplexan parasites transmitted by ticks to vertebrates that act as carriers and hosts ([@bib3]). Tick vector distribution, tick infectivity, persistence of the carrier state in the host species and host specificity determine parasite prevalence ([@bib15]). This specificity may encompass restriction to a single species, a limited number of species or specific evolutionary lineages ([@bib15]; [@bib31], [@bib32]). The determinants of host specificity remain unclear, although parasite-host-tick co-evolution for piroplasms has been considered ([@bib10]). However, incidental records for *Theileria* in exotic hosts question the concept of host specificity and may have implications for hypotheses on clinical disease etiology, epidemiology, geographic distribution and speciation ([@bib15]). In the current study we investigated the host specificity of *Theileria* sp. (buffalo).

It was posed that *Theileria* sp. (buffalo) show host specificity for African buffalo (*Syncerus caffer*) based on extensive screening of cattle in Uganda and South Africa in regions where this natural infection occurs ([@bib25], [@bib26]; [@bib38]; [@bib14], [@bib16]; [@bib28], [@bib30]; [@bib22]). However, recent studies aimed at investigating the host specificity of *Theileria parva* in buffalo, cattle and waterbuck in Kenya indicated a high prevalence of *T.* sp. (buffalo) in cattle ([@bib9]; [@bib4]), suggesting that *T*. sp. (buffalo) is not specific for African buffalo. However, the latter studies were restricted to a single farm (Marula) in Kenya (East Africa) where cattle and African buffalo share pastures. In South Africa, African buffalo and cattle are not allowed to share the same pastures, to limit the risk of Corridor disease (CD) outbreaks caused by transmission of *T. parva* from infected buffalo to cattle by the brown ear ticks, *Rhipicephalus appendiculatus* and *Rhipicephalus zambeziensis* (South African Animal Disease Act (Act 35 of 1984). Recently (2013), a CD outbreak did occur on a ranch (Bedrog) where cattle were allowed to graze on pastures frequented by African buffalo ([@bib12]). This presented an opportunity to investigate the host specificity of *T*. sp. (buffalo) and to determine the potential carrier state of this species in cattle, since the buffalo resident on the ranch were infected with *T. parva* ([@bib12]) and *T*. sp. (buffalo). The current study shows that while *T.* sp. (buffalo) can be detected in cattle, its epidemiology is closer to that of buffalo-adapted *T. parva*, where the duration of a definitive carrier state in cattle has yet to be defined.

2. Materials and methods {#sec2}
========================

2.1. Ethics approvals {#sec2.1}
---------------------

Animal experiments were approved by the Animal Ethics Committee of the Agricultural Research Council -- Onderstepoort Veterinary Research (ARC-OVR) (AEC12.11; AEC11.13; AEC03.14).

2.2. Sample collection {#sec2.2}
----------------------

Cattle were introduced onto a game ranch in 2013 (Bedrog, KwaZulu-Natal) within the tick vector endemic area that harbored buffalo. This resulted in an extensive CD outbreak among the cattle ([@bib12]). After the CD outbreak was diagnosed, cattle were block treated with oxytetracycline, dipped and moved to a tick free pen for observation and sampling for a period of three months. Samples analyzed in the current study were collected from cattle and buffalo during the investigation of the CD outbreak on Bedrog ranch ([@bib12]). This included 69 cattle sampled on 3 December 2013 shortly after the CD outbreak was reported, 100 cattle sampled on 14 January 2014 and 96 cattle sampled on 11 March 2014 during follow up visits, respectively. In addition, all 19 African buffalo from the ranch were sampled on 02 December 2013 (n = 9) and 21 January 2014 (n = 10). Buffalo from the Kruger National Park (KNP; n = 239) and the Hluhluwe-Imfolozi National Park (HIP; n = 94) as well as cattle (mixed Nguni breeds; n = 93) from diptanks adjacent to the parks previously screened for *Theileria taurotragi* ([@bib31]), were also included in the analysis.

All buffalo in the study were immobilized with a combination of etorphine hydrochloride (M99®; Novartis, South Africa) and azaperone tranquillizer (StresniT; Bayer Pharmaceutical, South Africa). The dose was approximately 8 mg etorphine hydrochloride with 100 mg azaperone adjusted according to estimated body mass. The anesthesia was reversed by intravenous administration of diprenorphine hydrochloride (M5050; Novartis) and all the animals were observed until they were mobile, a process that generally took about 2--5 min.

*2.3*. DNA extraction and real-time hybridization assays for T. parva *and* T. *sp. (buffalo)* {#sec2.3}
----------------------------------------------------------------------------------------------

DNA was extracted from 200 μl blood and eluted in 100 μl elution buffer using automated MagNa Pure technology (Roche Diagnostics, Mannheim, Germany). Each PCR reaction included 2.5 μl of DNA (\~15--50 ng/μl). Real-time hybridization assays were used to test the samples for the presence of *T. parva* DNA using the LightCycler® 2.0 (Roche Diagnostics, Mannheim, Germany) and for *T.* sp. (buffalo) using LightCycler® 480 (Roche Diagnostics, Mannheim, Germany) as previously described ([@bib28], [@bib29], [@bib30]). Crossing-point (CP) values were calculated by the qualitative analysis mode of the LightCycler 4.0 software (Roche Diagnostics, Mannheim, Germany).

Briefly, for *T. parva* the Hybrid II assay was setup with 2 μL LightCycler-FastStart DNA Master PLUS HybProbe (Roche Diagnostics, Mannheim, Germany), 2 μL LightCycler® 480 Genotyping Master (Roche Diagnostics, Mannheim, Germany), 1U UDG (Roche Diagnostics, Mannheim, Germany), 0·5 pmol TgF forward (TgF: 5′-GGTAATTCCAGCTCCAATAG-3′) and TpR reverse (TpR: 5′-AAAGTAAACATCCAGACAAAGCG-3') primer, 0·1 pmol each of the *T. parva* specific anchor (Anchor: 5′-GGGTCTCTGCATGTGGCTTAT--FL) and probe (Probe: 5′-LCRed640-TCGGACGGAGTTCGCT---PH) pairs (final volume of 20 μl). Reaction conditions included an initial UDG activation step (40 °C, 10 min) and a pre-incubation step (95 °C, 10 min). An initial 10 cycles of denaturation (95 °C, 10 s), annealing (60 °C, 10 s) and extension (72 °C, 15 s), followed by a touch-down procedure (60--56 °C, 15 cycles), followed by 20 cycles at 56 °C. These conditions were used on both Roche LightCycler® 2.0 and LightCycler® 480 systems (Roche Diagnostics, Mannheim, Germany) as described ([@bib29]). A cutoff of 37 °C was used.

For *T*. sp. (buffalo), primers utilized was a forward (TpF: CTGCATCGCTGTGTCCCTT) and reverse (TgR: ACCAACAAAATAGAACCAAAGTC) primer set with specific anchor (TpA: GGGTCTCTGCATGTGGCTTAT--FL) and sensor (TsBuff: (LC640-TC[A]{.ul}GACGGAGTT[TA]{.ul}CT-PH; underlined bases indicate locked nucleic acids) probes. Assay conditions included 2 μL LightCycler-FastStart DNA Master PLUS HybProbe (Roche Diagnostics, Mannheim, Germany), 2 μL LightCycler® 480 Genotyping Master (Roche Diagnostics, Mannheim, Germany), 1U UDG (Roche Diagnostics, Mannheim, Germany), 0·5 pmol forward and reverse primer, 0·1 pmol each of the hybridization anchor and probe pairs (final volume of 20 μL). Reaction conditions included UDG activation (40 °C, 10 min) and a preincubation (95 °C, 10min), followed by 45 cycles of denaturation (95 °C, 10 s), annealing (58 °C, 10 s) and extension (72 °C, 15 s). Melting curves were obtained by ramping from 40 to 75 °C (5 data acquisitions per degree). Runs were performed using the LightCycler® 480 system and CP values calculated using the LightCycler Version 1.5.0 software as described ([@bib30]). A cutoff of 37 °C was used.

2.4. Monitoring cattle under controlled conditions {#sec2.4}
--------------------------------------------------

Five cattle positive for *T. parva* (B24, B53, B120, B163, B164) and five cattle positive for *T.* sp. (buffalo) (B21, B79, B121, B123, B631) were moved from Bedrog to ARC-OVR for long term monitoring. Upon arrival B121 tested positive for *T. parva* and negative for *T.* sp. (buffalo) and was monitored as such. Cattle were kept under tick-free quarantine conditions and bled on a weekly basis for testing. Two animals positive for *T. parva* (B53, B120) and one animal positive for *T.* sp. (buffalo) (B21) were splenectomized on 5 August 2014 (8 months after CD outbreak) using standard procedures used for blood vaccine production at the institute by competent veterinarians.

2.5. Infection of a naive African buffalo and splenectomized Hereford with macroschizont-infected lymphoblastoid cell culture material {#sec2.5}
--------------------------------------------------------------------------------------------------------------------------------------

A *T.* sp. (buffalo) macroschizont-infected lymphoblastoid cell culture previously isolated from an African buffalo ([@bib39]), was used to infect a naïve African buffalo (Buffalo 114) as well as a splenectomized Hereford bovine by intravenous needle inoculation. The cell culture material was propagated as previously described in RPMI 1640 (Gibco 82400) containing 25 mM HEPES, 2 g/l sodium bicarbonate, and Glutamax^R^, supplemented with 10% (v/v) heat-inactivated fetal bovine serum, 0.2 mM hypoxanthine, 100 IU/ml penicillin, and 100 μg/ml streptomycin and was grown at 37 °C ([@bib39]). Both animals were housed in the East Coast fever quarantine complex at ARC-OVR and were confirmed negative for *Babesia* and *Theileria* parasites using real-time PCR and blood smear analysis. The immobilized buffalo (section [2.2](#sec2.2){ref-type="sec"}) received 50 ml of cell culture material (10 passages from frozen stock) intravenously containing a total of 8.28 × 10^7^ infected cells (macroschizont- and microschizont-infected lymphoblastoid cells). The Hereford was injected intravenously with 30 ml of cell culture (14 passages from frozen stock) containing a total of 7.98 × 10^8^ infected cells. Animals were monitored for any adverse clinical signs, and the bovine for *Theileria* piroplasms using Giemsa stained blood smears. Both animals were bled on day 35 post infection to confirm successful transmission of *T.* sp. (buffalo) infection using real-time PCR as well as with Giemsa stained blood smears.

3. Results {#sec3}
==========

3.1. PCR assay results for cattle and buffalo during a CD outbreak {#sec3.1}
------------------------------------------------------------------

Testing of 19 African buffalo from the ranch sampled on 02 December 2013 and 21 January 2014 indicated that 100% were positive for *T. parva* and 95% for *T.* sp. (buffalo), resulting in 95% co-infection ([Table 1](#tbl1){ref-type="table"}). In the case of *T. parva*, 46% of cattle were qPCR positive on the first sampling, which then decreased to 23% and 24% in consecutive months. For *T.* sp. (buffalo), 14% cattle tested positive during the first sampling and this value increased to 27% and 22% in consecutive months. This resulted in 9% co-infection for *T. parva* and *T*. sp. (buffalo).Table 1Summary of results for buffalo from Kruger National Park (KNP) and Hluhluwe-Imfolozi Park (HIP) and buffalo and cattle from Bedrog.Table 1LocalitySpeciesAnimals (n)*T.* sp. (buffalo)\
Number (% + 95% CI)*T. parva*\
Number (%: 95% CI)*Co-infections*\
Number (%: 95% CI)KNPBuffalo23987 (36%: 32-43)173 (72%: 66-78)72 (30%: 25-36)HIPBuffalo9494 (100%: 96-100)86 (91%: 84-96)86 (91%: 84 - 96)  Bedrog (02/12/2013)Buffalo98 (89%: 56-98)9 (100%: 70-100)8 (89%: 56-98)Bedrog (21/01/2014)Buffalo1010 (100%: 72-100)10 (100%: 72-100)10 (100%: 72-100)Buffalo (Total)Buffalo1918 (95%: 75-99)19 (100%: 83-100)18 (95%: 75-99)Bedrog (03/12/2013)Cattle6910 (14%: 8-25)32 (46%: 35-58)5 (7%: 3-16)Bedrog (14/01/2014)Cattle10027 (27%: 19-36)23 (23%: 16-32)12 (12%: 7-20)Bedrog (11/03/2014)Cattle9621 (22%: 15-31)23 (24%: 17-33)7 (7%: 4-14)Cattle (Total)Cattle26558 (22%: 17-27)78 (29%: 24-35)24 (9%: 6-13)

Comparative data for buffalo sampled in National Parks indicate that 72% and 91% of buffalo tested positive for *T. parva* in the KNP and HIP, respectively ([Table 1](#tbl1){ref-type="table"}). Only 36% of buffalo tested positive for *T*. sp. (buffalo) in the KNP, resulting in low co-infection of 30% for *T. parva*. Conversely, 100% of buffalo from HIP were positive for *T*. sp. (buffalo), resulting in 91% co-infection with *T. parva*.

3.2. Comparison of [T. parva]{.ul}*and*[T.]{.ul}*sp. (buffalo)* CP values for various samples {#sec3.2}
---------------------------------------------------------------------------------------------

In the case of *T. parva*, cattle from the CD outbreak showed an initial CP value range of 22--37 (average 31.8 ± 2.9), but this increased to 32-37 (average 34.7 ± 1.0) during subsequent samplings ([Fig. 1](#fig1){ref-type="fig"}). Buffalo from Bedrog showed CP value ranges from 20 to 30 (average 24.9 ± 2.2), which compared well with those from buffalo from the endemic KNP and HIP which showed CP value ranges from 20 to 35 (average: 26.8 ± 2.8) ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Frequency distribution curves for *Theileria parva* and *Theileria* sp. (buffalo) positive animals. Indicated are frequency distribution plots of the CP values and the percentage observed in buffalo from National Parks, buffalo from the Bedrog ranch, and cattle from the Bedrog ranch sampled during the outbreak (3/12/2013) and monitored afterwards for *T. parva* (top panel) and *T.* sp. (buffalo) (bottom panel).Fig. 1

For *T.* sp. (buffalo), CP values in cattle from Bedrog ranged from 31 to 33 (32.5 ± 0.77) during the first sampling shortly after the CD outbreak was identified, from 32 to 35 (33.7 ± 0.6) during the second sampling one month later and from 31 to 34 (32.8 ± 0.68) in the third month ([Fig. 1](#fig1){ref-type="fig"}). CP values in buffalo from Bedrog ranged from 22 to 30 (average 27.9 ± 2.0), comparing well with buffalo from endemic which ranged from 23 to 35 (average: 28.8 ± 2.4) ([Fig. 1](#fig1){ref-type="fig"}).

3.3. Monitoring T. parva *and* T. *sp. (buffalo)* positive cattle {#sec3.3}
-----------------------------------------------------------------

Six cattle (B24, B53, B120, B121, B163, B164) positive for *T. parva* were moved from Bedrog to ARC-OVR for long term monitoring. One animal (B24) became negative shortly after arrival and did not test positive over a 24-month period. One animal (B164) with intact spleen that showed an increase in parasitemia died of natural causes \~ one year into the monitoring period. Two animals (B53 and B120) were splenectomized a week after their CP values reached the PCR cutoff value (37 cycles) on 05 August 2014 (8 months after the outbreak). The animals showed intermitted CP values that fluctuated below the PCR cutoff value before steadily decreasing (increased parasitemia) \~6 months after splenectomy. For the non-splenectomized animals (B121 and B163) the CP values fluctuated around the detection limit ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2Monitoring of *Theileria parva* and *Theileria* sp. (buffalo) positive animals over a period of 24 months. The gray shaded areas indicate CP values below the cut-off of the PCR assays. Stars indicate animals that were splenectomized and the arrow indicate the date of splenectomy. The cross indicates an animal that died of natural causes.Fig. 2

Four cattle (B21, B79, B123, B631) positive for *T.* sp. (buffalo) were moved from Bedrog to ARC-OVR for long term monitoring. All animals became PCR negative within 5 months, except for B79 for which CP values fluctuated around the cut-off for \~2 years of testing. B123 and B631 remained negative for the duration of the testing. One animal (B21) was splenectomized a week after its CP value reached the cutoff, after which it tested negative for \~6 months before it became PCR positive again ([Fig. 2](#fig2){ref-type="fig"}). This animal remained positive to date with a trend of detectable but fluctuating parasitemia ([Fig. 2](#fig2){ref-type="fig"}).

3.4. Infection of an African buffalo and a bovine using a macroschizont-infected lymphoblastoid cell culture of [T]{.ul}*. sp. (buffalo)* {#sec3.4}
-----------------------------------------------------------------------------------------------------------------------------------------

Neither the bovine nor the African buffalo showed adverse signs after infection using the cell culture material. On day 35 post infection both animals were monitored for the appearance of piroplasms using Giemsa stained smears and for the presence of *T.* sp. (buffalo) using real-time PCR. Buffalo 114 showed the presence of piroplasms and schizonts and tested positive for *T.* sp. (buffalo) using real-time PCR with a CP value of 33.2. The bovine did not show the presence of any schizonts or piroplasms and tested negative using real-time PCR.

4. Discussion {#sec4}
=============

*Theileria* sp. (buffalo) remains an enigmatic parasite. It was first identified as a potential *T. parva* schizont cell culture isolate from African buffalo, that gave monoclonal antibody profiles different from that of other *T. parva* isolates ([@bib7]). Sequencing of the 18S rRNA hypervariable region indicated that its sequence differed from that of *T. parva* and it was tentatively suggested that it is a new species designated as *T.* sp. (buffalo) ([@bib1]). Its status as unique species from *T. parva* has been established using 18S rRNA, S5 ribosomal, cytochrome oxidase I, polymorphic immunodominant protein (PIM), Tp6, Tp7 and Tp8 genes ([@bib14]; [@bib30]; [@bib4]). It was subsequently shown to extensively infect African buffalo from Uganda to South Africa ([@bib2]; [@bib6]; [@bib14]; [@bib26], [@bib27]; [@bib30]).

While *T*. sp. (buffalo) has been considered to be host specific for African buffalo, recent reports suggest that it could also infect cattle ([@bib9]; [@bib4]). Even so, its epidemiology in cattle continues to present some conundrums. Screening of a large number of cattle from *R. appendiculatus* endemic regions in South Africa (regions known to be endemic for *T*. sp. (buffalo) in buffalo), did not detect *T.* sp. (buffalo) to date ([@bib28]; [@bib16]). In Lake Mburo National Park (Uganda, East Africa), none of the cattle (n = 144) tested were positive for *T.* sp. (buffalo), even though all buffalo (n = 19; 100%) were positive ([@bib26]). In contrast, a recent study in Kenya (East Africa) where cattle and buffalo grazed on the same pastures (Marula farm), detected extremely high levels of infection for *T.* sp. (buffalo) in cattle (n = 63/86; 73%) ([@bib9]), suggesting a possible carrier state. Another study from the same farm identified 5/22 schizont cell lines (23%) from cattle to be *T.* sp. (buffalo) derived ([@bib4]). In another study from western Kenya (East Africa), a cohort of calves (n = 453) sampled across 20 random localities, showed infection for 406 animals at 51 weeks of monitoring, of all common *Theileria* species infecting cattle including *Theileria mutans*, *T. parva*, *T. taurotragi* and *Theileria velifera* ([@bib22]). None was infected with *T.* sp. (buffalo) or *Theileria buffeli*. Another study that sampled cattle from two farms from central Kenya (East Africa), detected *T. parva* infection on both farms with prevalence ranging from 30 to 32% ([@bib19]), which is comparable to previous epidemiological studies in Kenya ([@bib24]). In the previously refereed study, only one animal was positive for *T.* sp. (buffalo) at a prevalence of 0.6% ([@bib19]). These observations in cattle contrast sharply with the prevalence of *T.* sp. (buffalo) in buffalo that generally range from 40 to 100% in endemic areas ([@bib30]).

Cattle under carrier conditions (non-clinical disease progression) have been routinely tested since 2008 from regions in South Africa assumed to be endemic for *T.* sp. (buffalo) ([@bib30]). Except for the Bedrog ranch, none of these cattle has tested positive for *T.* sp. (buffalo). A possible reason for this is the strict quarantine measures imposed in South Africa to keep buffalo and cattle segregated, in order to limit transmission of CD from buffalo to cattle. As such, opportunity for transmission of *T.* sp. (buffalo) from buffalo to cattle via its tick vector would be limited and may explain the epidemiological distribution observed. Even so, significant CD outbreaks occur on a regular basis where cattle and buffalo come into contact within the CD endemic region of South Africa ([@bib18]), to assume that cattle would be exposed to *T.* sp. (buffalo). In this regard, CD outbreaks have been monitored for more than 15 years and no evidence exist that the disease has spread to areas outside the CD endemic area, even though the tick vector distribution is much wider ([@bib28]). This strongly argues against a natural carrier state in cattle for buffalo-adapted *T. parva* from South Africa, even though therapeutic carrier states may be induced with oxytetracycline ([@bib12]). This contrasts to the very rapid spread of East Coast fever when the disease established itself within a 10-year period from 1902 to 1912 throughout its vector distribution in South Africa, during the East Coast fever epidemic ([@bib20]; [@bib13]; [@bib23]). The same argument may be applied to *T.* sp. (buffalo), i.e. it does not show an extensive distribution in cattle in South Africa even though cattle contact with its vector tick and the parasite may be expected on a regular basis. The epidemiology of *T.* sp. (buffalo) is therefore similar to that of buffalo-adapted *T. parva* in cattle, and would suggest that both parasites, even though they can infect cattle, have not adapted to a stable carrier state yet.

The Bedrog ranch presented an interesting opportunity to study possible transmission from buffalo to naïve cattle during its CD outbreak, since most buffalo on the ranch were infected with *T.* sp. (buffalo). In this case, 27% of cattle tested positive for *T.* sp. (buffalo) one month after the initial outbreak. Follow-up monitoring over a period of two months indicated that the prevalence dropped to 22% (CP values ranged from 31 to 35). Animals monitored for a longer period in the absence of infected tick vectors lost the infection completely, except for one animal splenectomized. A trend of lower CP values indicated that the parasitemia for *T.* sp. (buffalo) slowly increased for this positive animal. A similar trend was observed in a *T. parva* positive splenectomized animal. This suggests that buffalo-derived *T. parva* and *T.* sp. (buffalo) is cleared from intact animals ([@bib18]), and that the spleen and its related immunity play an important role in this process. The results also support the observations by [@bib21] that splenectomy can result in recurrence of parasitemia of buffalo-derived *T. parva*, most probably if performed while sufficient numbers of parasites are still circulating. In contrast, field derived cattle that previously tested positive for *T. parva* and subsequently became PCR negative ([@bib18]), were subsequently splenectomized but did not show *T. parva* recurrence (Latif, personal observation). According to some authors ([@bib12]), the only difference between these latter cattle and the carriers from Bedrog ranch were oxytetracycline treatment.

A confounding factor in the current study is the fact that animals were block-treated with oxytetracycline during the peak of the CD outbreak ([@bib12]). Oxytetracycline is used as part of the infection and treatment regime during East Coast fever vaccination ([@bib37]). It has also been shown that treatment with oxytetracycline during early stages of infection can prevent death due to *T. parva* ([@bib5]). Furthermore, infection and treatment with oxytetracycline can lead to a carrier-state ([@bib17]). To date, the mechanism of tetracycline on apicomplexan parasite biology has not been resolved, although perturbation of mitochondrial protein synthesis and parasite differentiation has been implicated ([@bib34]; [@bib33]; [@bib8]). It may therefore be possible that non-natural carrier-states can be created using chemoprophylaxis and may explain in part the relatively long period that cattle were PCR positive for *T.* sp. (buffalo) in the current study (\>3 months) as well as the cattle positive for *T. parva*.

Overall, the data suggest that cattle may be infected by *T.* sp. (buffalo) and that infected schizonts may persist for some time ([@bib4]). However, transformation, maturation and merozoite production to produce a long term carrier state may not be viable. This may suggest that schizonts can persist for prolonged periods in the vertebrate host without progressing to the piroplasm stage, while animals remain PCR positive. *Theileria parva* schizonts could be cultured 210 days (7 months) after infection ([@bib11]), making this a possibility for both *T*. sp. (buffalo) and buffalo-adapted *T. parva*. Alternative explanations may be that the strains between South Africa, Uganda and Kenya differ to such an extent to support different host-carrier behavior. *Theileria* sp. (buffalo) may then mimic the phenomenon observed between buffalo and cattle-derived *T. parva* in East and South Africa. In this case, the single annual lifecycle of *R. appendiculatus* in South Africa does not allow maintenance of a carrier state in cattle, because parasites are cleared in cattle before nymphal pickup can occur ([@bib18]). In East Africa, the concurrent presence of all life stages enables tick pickup from transient carriers and transmission to new cattle hosts. The tick vector for *T.* sp. (buffalo) would therefore also have a single annual life cycle in South Africa (even though the tick vector remains unknown), but would explain the absence of a carrier state in cattle in that geographic region.

Immunity to infection may partially explain the results observed. In this case limited genetic diversity within geographic populations, linked with maternal immunity may limit subsequent homologous infection resulting in low prevalence. In the case of CD and cattle this may result in sterile immunity and loss of a parasitaemic carrier state, most probably because a stable carrier state is not well established in cattle. Results from the currently study suggest that for *T.* sp. (buffalo) a stable carrier state in cattle is also not supported. The prevalence data in the current study for Bedrog for *T.* sp. (buffalo) and *T. parva* in cattle (14-24% and 23-46%, respectively), and that obtained at Marula (73% and 76%, respectively), also differs significantly, suggesting that additional factors may play a role in disease transmission in these regions such as climate, tick infectivity or tick vector capacity. In the case of buffalo, high genetic diversity of *T.* sp. (buffalo) and *T. parva* will result in heterologous challenge and higher prevalence. This would, however, not explain the high incidence observed for *T. parva* and *T.* sp. (buffalo) in geographically restricted areas such as HIP ([@bib30]). High incidences were also observed for other *Theileria* genotypes such as *T. mutans*-like 1, *T. mutans*-like 2 and *T. mutans*-like 3 ([@bib16]). This would suggest that while immunity may play a role in prevalence, propensity for the natural carrier state may also have an impact.

The results from the current study have interesting implications for surveys of mammalian hosts for *Theileria* parasites using molecular methods and the potential epidemiological conclusions that may be derived from these studies. Detection of parasites in a vertebrate host may only imply recent transmission by the tick, or transient infection of host leucocytes, or establishment of chemotherapeutic-induced carrier states, especially where oxytetracycline treatment forms part of a regular treatment regime. It does not imply efficient leucocyte transformation, maturation to the piroplasm stage, or a long term carrier state in the host that would support infection of the tick vector under natural conditions (no prophylaxis). Useful conclusions regarding parasite epidemiology and host carrier status requires long term follow up over several seasons and sampling of sufficient host numbers in vector endemic regions. Incidental detection of *Theileria* in hosts not considered natural carriers should be contrasted to endemic stability expected for the *Theileria* genus in natural hosts and should be factored into epidemiological considerations regarding parasite transmission. An interesting case in point would be the infection of waterbuck (*Kobus defassa*) with *T. parva* under controlled conditions, while under conditions of co-grazing with infected buffalo no evidence was found for a carrier state ([@bib35], [@bib36]; [@bib9]).

5. Conclusions {#sec5}
==============

While *T.* sp. (buffalo) can infect cattle, no evidence exists that a long-term carrier state occurs in cattle that would suggest that they are natural carrier hosts. This is similar to buffalo-adapted *T. parva* that causes CD in cattle. Confirmation of long-term carrier status is an important consideration in the epidemiology of theilerial diseases. While short-term incidental infections of non-optimal hosts may occur, these events may play a negligible part in the epidemiology of *Theileria* parasites, especially where the tick vectors exhibit annual life cycles.
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